Listar Terapia Celular e Medicina Rexenerativa por autor "Carmona, Loreto"
Mostrando ítems 1-3 de 3
-
Exploring the remission concept in rheumatoid arthritis with patients and rheumatologists: time for a new approach?
Acebes, Carlos; Andreu, José Luis; Balsa, Alejandro; Batlle, Enrique; De-Toro, Javier; García Llorente, Francisco; Hernández, María Victoria; Fernández-Gutiérrez, Benjamín; Hidalgo-Calleja, Cristina; Mayordomo, Lucía; Naredo, Esperanza; Narváez, Francisco Javier; Ortiz, Ana M.; Pablos, José Luis; Pérez-Sandoval, Trinidad; Rodríguez-Lozano, Carlos; Sánchez-Pernaute, Olga; Usón, Jacqueline; Negrón, José Bernardo; Loza, Estíbaliz; Carmona, Loreto; Gómez Castro, Susana; Montoro Álvarez, María (Clinical and Experimental Rheumatology, 2017-09)[Abstract] Objectives: To explore the remission concept in rheumatoid arthritis (RA) and to compare remission definitions and related concepts between rheumatologists and patients with the purpose of identifying ... -
Patients' perceptions on shared decision making during prescription of subcutaneous biological drug treatments for inflammatory arthritis: the RHEU-LIFE survey
De-Toro, Javier; González, Carlos M.; Cea-Calvo, Luis; Arteaga, María J.; Fernández, Sabela; Carmona, Loreto; Otón, Teresa (Wiley, 2020-08-24)[Abstract] Objectives: The aim of this study was to explore the preferences of patients with rheumatic diseases and their perceived experience regarding participation in shared decision making (SDM) when they were prescribed ... -
Perceptions of patients with rheumatic diseases treated with subcutaneous biologicals on their level of information: RHEU-LIFE survey
De-Toro, Javier; Cea-Calvo, Luis; Batlle, Enrique; Carmona, Loreto; Arteaga, María J.; Fernández, Sabela; González, Carlos M. (Elsevier, 2018-12-21)[Abstract] Objective: To investigate, in Spanish patients with rheumatic diseases treated with subcutaneous biological drugs, their sources of information, which sources they consider most relevant, and their satisfaction ...